Update on Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA‐ALCL)

Update on Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA‐ALCL)

Women who are concerned about their breast implants following reports of a study linking infection caused by implants to a rare cancer, anaplastic large cell lymphoma (ALCL), should discuss their concerns with their doctor.

The Therapeutic Goods Authority continues not to recommend preventative breast implant removal in patients without symptoms or other abnormality.

ASPS is developing a national register of member surgeons who are willing to see concerned women with symptoms and assess their implants for no out-of-pocket expense consultation. The patients first option should be to see the surgeon who put the implants in but if they can’t or don’t want to, then members on the register will see the patient for an assessment with a referral from their GP.

This initial consultation is an opportunity to discuss concerns. If the patient chooses to undertake further investigation or commit to a procedure, subsequent costs may be incurred.

The register can be accessed here.


Media enquiries: Sandra Renowden 0403823218 or sandra@mohrpr.com.au

Featured Stories

Media release heading on ASPS background
ASPS say proposed changes to registration practices of SIMGs will put patients at risk

President of the Australian Society of Plastic Surgeons, Dr David…

Continue reading

26 June 2025

2025 ASPS Plastic Surgery Congress

PSC 2025 returns with high-quality content and presentations of the…

Register
Professor Anand Deva face to camera in his study
Q&A with Professor Anand Deva – Breast Implant Illness

In this video Q&A Professor Anand Deva discusses issues that…

See more

Further Information